difficult to think of another Centre of its kind
with the same track record of contributions to
the pharmaceutical industry.
SUPPORT SYSTEM
Desbien says NEOMED has been behind many
Canadian Life Sciences success stories, and
points to enGene Inc. as an illustration of the
NEOMED Innovation Centre doing what is does
best. enGene is built around an innovative oral
gene-delivery formulation called the ‘Gene
Pill’ that has the potential for the oral delivery
of a wide range of protein drugs. Starting as
a four-person team, NEOMED helped enGene
flourish into a 50-person team in only three
years, with established partnerships with large
pharmaceutical companies. By providing the
best ‘set-up’ for enGene, meaning, laborato-
ries, vents, space made to the specific regula-
tions, and R&D support services, enGene has
become one of the country’s biotech leaders.
“This NEOMED model is unique and it has
been ideal for enGene’s growth trajectory,”
“Our job at NEOMED is to
take care of all these things so
our clients can focus on their
business.”
---------------------------------
Pierre-Yves Desbiens
CEO and Head of Operations
SEPTEMBER 2018 | BUSINESS ELITE CANADA 7
